Purpose: We report a case where tacrolimus eye drops may have alleviated immune checkpoint inhibitor (ICI)-related conjunctivitis attributed to nivolumab.
Observations: A 61-year-old female complained of conjunctival hyperemia and eyelid swelling in both eyes. The patient was previously undergoing treatment for gastric cancer with nivolumab, with the final dose administered one week before the first ophthalmology visit. Initially, the patient was diagnosed with allergic conjunctivitis, managed with 0.1 % fluorometholone eye drops, 4 times daily in both eyes, but the symptoms did not improve despite 27 weeks of treatment, ICI-related conjunctivitis was considered, and the patient was prescribed with, 0.1 % tacrolimus eye drops twice daily in both eyes. One week later, there was a remarkable improvement in the conjunctival symptoms. Three months after, the conjunctival hyperemia reduced and swelling disappeared in both eyes, and, the frequency of instillation was reduced to once daily. The condition remains in remission with 0.1 % tacrolimus eye drops applied once daily in both eyes.
Conclusions: Tacrolimus eye drops may have played a role to suppress ICI-related conjunctivitis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849634 | PMC |
| http://dx.doi.org/10.1016/j.ajoc.2025.102268 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Noninvasive ocular delivery of adalimumab-loaded nanostructured lipid carriers for targeted retinitis pigmentosa therapy.
Biomed Pharmacother
March 2025
Group of Pathophysiology and Therapies for Vision Disorders, Príncipe Felipe Research Center (CIPF), Eduardo Primo Yúfera 3, Valencia 46012, Spain; Joint Research Unit on Rare Diseases CIPF-Health Research Institute Hospital La Fe (IIS-La Fe), Valencia 46026, Spain; Biomedical Research Networking Center in Rare Diseases (CIBER-ER), Institute of Health Carlos III, Monforte de Lemos, 3-5. Pabellón 11, Madrid 28029, Spain; Catholic University of Valencia (UCV), Faculty of Health Sciences, Quevedo, 2, Valencia 46001, Spain. Electronic address:
Retinitis pigmentosa is a genetically heterogeneous retinal degeneration process. There is hardly any treatment available. It is associated with extensive chronic inflammation and the release of proinflammatory cytokines such as TNFα.
View Article and Find Full Text PDFInterferon alpha-2b versus 5-fluorouracil as primary treatment modalities for ocular surface squamous neoplasia: a study of 116 eyes.
Int Ophthalmol
March 2025
The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, L V Prasad Marg, Road no 2, Banjara Hills, Hyderabad, Telangana, 500034, India.
Purpose: To compare the efficacy and side-effect profile of interferon alpha-2b (IFNα2B) and topical 5-fluorouracil (5-FU) as primary treatment modalities for ocular surface squamous neoplasia (OSSN).
Methods: Retrospective comparative study of 116 OSSN eyes treated with topical 1 MIU IFNα2B with/without 5 MIU/cc subconjunctival injection (group 1) or topical 1% 5-FU (group 2) in mutually exclusive time periods of treatment.
Results: Of the 116 eyes with OSSN, 64 eyes belonged to group 1 and 52 eyes to group 2.
Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications.
J Med Microbiol
March 2025
Department of Ophthalmology, Kazakh-Russian Medical University, 71 Torekulov Str., 050000, Almaty, Republic of Kazakhstan.
Eye diseases are widespread all over the world and, if left untreated, can lead to blindness. The use of 0.05% cyclosporine A (CsA) solution for the treatment of dry eye causes a decrease in discomfort and pain and improves objective measures such as tear film breakdown time, Schirmer test results and Oxford scale scores due to its anti-inflammatory and immunomodulatory properties that contribute to improved tear film stability and tear production.
View Article and Find Full Text PDFMicrobial Contamination of Eye Drops: A Systematic Review and Meta-analysis.
J Patient Saf
March 2025
Department of Biomedical Science, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.
Objectives: To profile the array of microbial contaminants of eye drops, both native and non-native to the ocular surface, and associated factors for contamination.
Methods: Potentially relevant studies were retrieved from major bibliographic databases (PubMed, Scopus, and Web of Science). Data were extracted, and study-specific estimates of the contamination rates of topical ophthalmic solutions were combined using meta-analysis to obtain pooled results.
Topical tacrolimus versus dexamethasone in managing shield ulcer of vernal keratoconjunctivitis.
Med Hypothesis Discov Innov Ophthalmol
February 2025
Ophthalmology Division, Shahid Beheshti Clinic, Karaj, Alborz, Iran.
Background: Vernal keratoconjunctivitis (VKC) is a bilateral, chronic, allergic inflammation of the ocular surface with debilitating ocular signs and symptoms. We compared the efficacies and safeties of 1% tacrolimus eye drops and 1% dexamethasone eye drops in managing unilateral shield ulcers and corneal epitheliopathy secondary to VKC.
Methods: We recruited patients with unilateral shield ulcer and corneal epitheliopathy secondary to VKC in a tertiary referral center in southeast Iran during a 12-month period.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!